U.S. Professional Services Stock News

NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Cintas UniFirst Deal Reshapes Uniforms Leader And Investor Valuation Debate

Cintas, ticker NasdaqGS:CTAS, has agreed to acquire UniFirst in a cash and stock transaction. The deal is set to combine two major players in uniforms and facility services, pending customary approvals. The transaction is designed to expand Cintas reach across customers, service routes, and product offerings. Cintas comes into this planned acquisition with shares at $168.85 and a record of returns over multi year periods. The stock is down 7.1% over the past week, 15.0% over the past month,...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics Challenges Short Report As Valuation And Compliance Scrutinized

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Is It Too Late To Consider Arcellx (ACLX) After Its Strong 81% YTD Rally?

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...
NYSE:HMN
NYSE:HMNInsurance

Undervalued Small Caps With Insider Action Across Regions

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.
NYSE:KVYO
NYSE:KVYOSoftware

Exploring High Growth Tech Stocks In The US Market March 2026

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.
NYSE:ABBV
NYSE:ABBVBiotechs

3 Stocks That May Be Underestimated In March 2026

Over the last 7 days, the United States market has experienced a 1.6% decline, yet it has shown resilience with a 15% rise over the past year and an anticipated earnings growth of 16% annually in the coming years. In this environment, identifying stocks that may be underestimated requires looking beyond short-term fluctuations to find companies with strong fundamentals and potential for long-term value appreciation.
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

March 2026's Promising Penny Stocks To Watch

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.
NYSE:VLO
NYSE:VLOOil and Gas

US Stock Market Today S&P 500 Futures Steady As Inflation And Geopolitical Risks Persist

The Morning Bull - US Market Morning Update Friday, Mar, 27 2026 US stock futures are mixed this morning, with S&P 500 contracts hovering near flat as investors weigh higher borrowing costs against hotter inflation and geopolitical risk. The US 10 year Treasury yield is holding around 4.41%, which keeps pressure on everything from credit cards to business loans, while the average 30 year mortgage rate sits at 6.38%, keeping home buying more expensive. At the same time, Middle East tensions...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

SIGA Technologies Special Dividend Highlights Capital Return And Profit Pressures

SIGA Technologies (NasdaqGM:SIGA) has declared a special cash dividend for its shareholders. The announcement provides a direct cash return in addition to any regular dividend policy the company may have. The timing of the dividend decision highlights management's current view of the company’s cash position and capital needs. SIGA Technologies focuses on health security solutions, including products designed for infectious disease and biodefense settings. A special cash dividend draws...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Celcuity’s Priority Review Puts Gedatolisib And Investor Trade Offs In Focus

Celcuity (NasdaqCM:CELC) received FDA Priority Review for its New Drug Application for gedatolisib in advanced breast cancer. The Priority Review follows strong Phase 3 efficacy results from the VIKTORIA-1 trial in HR-positive, HER2-negative breast cancer. An additional Phase 3 readout for the PIK3CA mutant cohort is upcoming and could further influence treatment standards for this patient group. Celcuity focuses on targeted therapies for cancer, with gedatolisib as a key asset in its...